Explore more Johnson & Johnson sites:
Learn More About Janssen's Phase 3 COVID-19 Vaccine Candidate Clinical Trials
Please note that by clicking this link, you’ll be leaving jnj.com and going to a third-party website not governed by the jnj.com privacy policy.
Learn More
Please note that by clicking this link, you’ll be leaving jnj.com and going to a third-party website not governed by the jnj.com privacy policy.
With its Phase 3 clinical trial now fully enrolled, the Global Head of Research & Development at Janssen brings us up to speed on the progress of the company's vaccine candidate, including upcoming key milestones.
A potential COVID-19 vaccine. Passionate efforts toward achieving racial and social justice. Smarter, more sustainable product packaging. These are just a few of the resolutions company change makers are aiming to bring to light this year—and they're already hard at work on them.
Tracking the spread of the virus in real time. Analyzing data to learn more about who's most vulnerable. These are just a couple of ways the company's data science team is helping inform how to respond to the pandemic.
As the J.P. Morgan Healthcare Conference takes place this week, the President of Johnson & Johnson Innovation – JJDC, Inc. shares some of the scientific breakthroughs and collaborations his team is championing to help address the unmet needs and well-being of people around the world.
With COVID-19 dominating the news this year, chances are you've also read about clinical studies that are underway for investigational vaccines. For a glimpse at what the experience of participating in a clinical study is like, we spoke to people across the country who took part in a clinical trial.
Most people know about side effects, like hair loss, that can accompany cancer treatment. But chemotherapy can also impact your skin. Oncodermatologists and Johnson & Johnson scientists looked into how to care for such skin—leading to a new science-backed line of cleansers, moisturizers and balms designed with cancer patients in mind.
Johnson & Johnson has a long legacy of supporting the nursing community—and the challenges brought on by COVID-19 have only strengthened its commitment to find new ways to give back to these essential healthcare workers over the past year.
Johnson & Johnson is one of many companies hard at work on an investigational COVID-19 vaccine candidate, which includes recruiting adult participants around the world for our Phase 3 clinical trials known as ENSEMBLE. Please note that by clicking this link, you’ll be leaving jnj.com and going to a third-party website not governed by the jnj.com privacy policy.
Live Event
The Road to a Vaccine
In Season 2 of The Road to a Vaccine, host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.
Season 2, Episode 12
What We Now Know About How to Overcome COVID-19 in the U.S.
In the last episode of the year, Lisa Ling asks Taiwan’s former Vice President how the island has completely eliminated the disease. And Sean Penn and Ann Lee from the non-profit CORE talk about their efforts to fight COVID through improved testing.
December 22, 2020
-
What You're Talking About
-
Fact
1920. That’s when BAND-AID® Brand Adhesive Bandages were invented. Can you guess what inspired their creation?
Recent Johnson & Johnson Initiatives in the Spotlight
Learn more about the company’s latest groundbreaking programs, game-changing innovations and global partnerships—all aimed at helping change the trajectory of health for humanity.
